Good morning.
The market is pricing not one but two structural signals into AI today, and they're pulling in different directions. Tape composite: S&P futures flat, Nasdaq modestly green, SOX futures +1.2% — led by MU +3% in pre-market. Taiwan semi index hit another all-time high overnight. Dell is the mega-cap event: +31% AH, guiding FY revenue $140B-$168B, AI server +757% YoY, $51B backlog. That's real. That's the squeeze, not the new narrative.
Asia: Taiwan and Korea both green, ignoring Hegseth's Beijing speech entirely. Nikkei flat. The "geopolitics don't matter for AI supply chain" thesis survives another day.
Three themes frame the tape today:
1. THE TAIWAN SUPPLY CHAIN JUST CONFIRMED THE DELL NARRATIVE WITH PHYSICAL ORDERS. Hon Hai, Quanta, Pegatron, Wistron — all said the same thing yesterday: demand visibility into 2027, capacity is the binding constraint, not demand. Hon Hai's chairman: "if no black swan, very optimistic about H2." This is the chain talking in unison. PMs should take that as a higher-confidence signal than any single guide raise.
2. MEMORY SHORTAGE JUST UPGRADED FROM "HBM LOCAL" TO "12-INCH FAB GLOBAL." TrendForce raised CY26 memory revenue forecast from $551B to $889B. $889B. That's a 61% upward revision in one go. Winbond chairman directly stated: "the constraint is 12-inch fab cleanroom capacity, not any single product." DRAM shortage now spilling into NAND and NOR. This is the structural bull case for MU, and the ByteDance HBM-free chip story (per The Information) creates a fork: do hyperscalers go HBM-free, or is that just a Chinese workaround? The market is pricing the former as noise today. We'll see.
3. POWER IS THE NEXT BINDING CONSTRAINT, AND THE MARKET STILL ISN'T PRICING IT. ERCOT interconnection requests massively exceed underwrite capacity. 3-7 year queue for grid hookups. That means behind-the-meter generation (nuclear, fuel cells) is the only path to deploy outside that timeline. 30-50% of CY26 DC capacity expected to be delayed per fuel cell adoption data. This is real. BE and OKLO are the direct plays here, but the read-through for every hyperscaler capex plan is: are you building where power is available?
We'll hit up MU, DELL, and S first, then get to the power and fuel cell plays — BE and OKLO need a deeper look.
MDB is the real deal. Clean beat-and-raise quarter, Atlas accelerating, margins expanding, and guide raised by more than the beat. The stock is up 72% over the past year but still gets dinged for a 22% YTD pullback – that's the setup. Most analysts now see a strategic platform story, not just a consumption ticker. PT range $315–$435, median ~$390, with only UBS and Macquarie on the sidelines.
Nine analyst notes, but the narrative is uniform. Bulls say: Atlas consumption accelerated on core workloads (not just AI hype), margins are inflecting, and the company is becoming a strategic database choice. Bears say: AI pull-through is still embryonic (contrast with Snowflake), valuation is stretched at 9x EV/CY27 sales, and the 72% run already prices in perfection. What's new: The guide raise was bigger than the beat, management explicitly called out Frontier Lab consumption and AI-native apps as drivers — that's incrementally bullish. Also CJ Desai's customer meetings boosted product roadmap confidence.
"MongoDB was clear that the upside was driven primarily by the core business, as any AI pull-through remains early-stage (in contrast to Snowflake)." — UBS
"MDB is a later-cycle winner given its position at the database layer, where adoption tends to follow once AI workloads move from experimentation into production." — Cantor Fitzgerald
Bull case (Stifel, Mizuho, Morgan Stanley, Cantor): Atlas is back to accelerating consumption on real workloads (not just AI tokens). NRR at 121% proves existing customers are scaling. cRPO up 70% gives 2-3 quarters of visible growth. Margins are expanding 200bps annually — MDB is approaching Rule of 40 (25% rev growth + 18% op margin = 43). AI tailwind is real, just early. Cantor calls it a "strategic component of the AI data stack." PTs $380-$435 imply 15-30% upside from here.
Bear case (UBS, Macquarie): The beat was mostly core, and the AI monetization story is still a promise. UBS says no material follow-through after Snowflake's print already lifted the stock 11% into earnings. Macquarie keeps Neutral at $315 — that's still below the current price. Valuation at 9x EV/CY27 sales is above the 3-year median and leaves no room for execution stumbles. The stock is up 72% in a year — the easy money has been made.
This is the most debated point. Bulls point to "accelerating Frontier Model Lab consumption" and "growing AI Native applications" (Stifel). Needham says "early stages of monetizing AI" but calls it a Conviction List Buy. Morgan Stanley says "AI tailwind to growth is on the horizon." Bears (UBS) explicitly say any AI pull-through is early-stage and contrast with Snowflake. My take: It's real but not massive yet. The bigger story is that the core database business is accelerating on its own — AI is gravy, not the main course.
Peers: SNOW (also beat on consumption, but guide was softer), DDOG (similar infra story, also seeing AI workloads). The common thread: consumption is back, enterprises are modernizing data stacks. MDB sits at the database layer, which tends to lag compute/monitoring. Cantor's "later-cycle" framing is right. If AI workloads move to production at scale, MDB benefits hard.
Thematic: Multi-manager PMs should watch for further acceleration in Atlas growth rates in Q2 (guide ~26%, Street whisper ~27%). cRPO growth is the leading indicator — 70% is absurdly strong for a $10B+ market cap company. Any sign of Q2 Atlas beating the 26% guide will send this back toward $400.
THE STREET IS SPLIT ON SENTINELONE – BUT THE MARGIN OF ERROR IS WIDE. Stock gets hammered 18% in after-hours after a Q1 that was... fine. Revenue $276.7M (21% y/y) missed midpoint of guidance by a whisker. ARR growth accelerated to 23% y/y, net new ARR hit a record +55% y/y. But billings growth of 14% missed the Street low. Management guides Q2 revenue growth to 19-20% (below consensus by ~110bps) and announces an 8% RIF – 230-240 heads, mostly go-to-market. The narrative is a tug-of-war: "ARR inflection is real" vs. "execution is still inconsistent and macro headwinds linger."
Price target range is $15 (DA Davidson, Neutral) to $24 (Cantor, Jefferies). Consensus is messy – 5 Buys, 1 Neutral, 1 Market Perform (Raymond James downgrade). Median around $20-22.
Q1 FY27 (April quarter) looked strong on the surface: ARR $1.163B (+23% y/y, beat consensus by ~$3M), EPS $0.04 (doubled the $0.02 estimate), operating margin 3.8% (vs 2.2% consensus). But revenue landed at $276.7M – below the midpoint of their own guidance – and calculated billings grew only 14% (vs Street-low 16%, consensus 21%). The miss was blamed on back-end loaded bookings and one partner deal with a ramping revenue component that fell short. Net new ARR of $44M was up 55% y/y – a record – but comps were easy (Attivo churn and pushouts in prior year). Adjusted for that, net new ARR grew ~15%. The RIF is structural: $45M annualized savings, reinvested into AI Security, Purple AI, Data, Cloud. Stock deserved some softness – but 18% down feels like the market pricing in a growth cliff that guidance doesn't support.
BULL (Cantor, Rosenblatt, Jefferies, BofA, TD Cowen, Citizens): "ARR acceleration is real" – 23% y/y ARR growth and record net new ARR (+55%) aren't being priced in after the drop. Operating margin expanded 550bps y/y to 4%, and guidance for FY op margin was raised 50bps. The RIF shows discipline, not desperation. Non-endpoint products now 50% of ARR, Prompt Security nearly doubled QoQ, and remaining performance obligations accelerated to 30% growth. The pullback is an overreaction – demand signals are better than headline noise.
"The demand signals are better than the headline reaction suggests despite the revenue miss and soft guidance." – Cantor Fitzgerald
"We view the guidance as appropriately prudent and believe the proactive realignment and reinvestment into AI security, data and cloud have overshadowed positive ARR and margin trends." – Rosenblatt
BEAR (Raymond James, DA Davidson, UBS): "Execution remains inconsistent." Revenue missed the midpoint of guidance – again. Billings growth of 14% is the low watermark against peers. The RIF of 8% is twice the size of the 2023 restructuring and includes go-to-market personnel – that's a headcount cut into your customer-facing capacity. CFO is only 60 days into the role; first official guidance. Macro and geopolitical headwinds are still cited as causing unfavorable invoice cycles. The stock ran up 50% from April 10 to earnings – some of that premium was bound to come out. AI tailwinds are taking longer to materialize than expected.
"Working capital metrics suggested a back-end weighted quarter... The restructuring involves changes to team structure and go-to-market strategy." – Raymond James (downgrade to Market Perform)
"Second-quarter net new ARR implied lower on callback versus prior expectations and consensus... Q2 revenue growth guidance 130bps below our estimate and 110bps below Street." – DA Davidson
New: The RIF (8% headcount reduction) – not just a cost cut, but a strategic pivot toward AI and productivity. Savings of $45M annualized, $25M charge in Q2. Management says no impact to go-to-market, but that's a hard claim to trust given the cuts include GTM personnel.
New: CFO Sonalee Parakh issued her first official guidance – only 60 days in. That's a risk factor, not a narrative edge.
New: Non-endpoint ARR now 50% of total – a milestone for platform expansion. Prompt Security nearly doubled QoQ. That's the positive incremental shift.
Already known: Macro headwinds, billings lumpiness, competitive landscape (CrowdStrike, Microsoft). The 20%+ revenue growth corridor was implied in prior guidance. The RIF was rumored.
Peer read-through: CrowdStrike (CRWD) – S's ARR acceleration to 23% is respectable but still lags CRWD's 30%+ growth. The RIF at S signals that even high-growth endpoint players are having to balance margin expansion with growth investment. CRWD's upcoming print will be read against this – if CRWD shows similar billings weakness, it's macro; if it beats, it's S-specific execution.
Narrative read-through: The "AI security" theme is alive – Purple AI, Prompt Security, Data, Cloud all driving non-endpoint growth to 50% of ARR. But the RIF shows that AI adoption is taking longer to monetize than hoped. For the broader TMT security space, this is a caution flag: AI tailwinds are real but not yet at escape velocity.
Positioning read-through: Stock down 18% after-hours – that's a violent move for a company that beat on ARR and margins. Suggests hedge funds were long into the print and got caught in the billings disappointment. The short interest likely increased. If you believe the bull case (and Rosenblatt's "overreaction" call), this becomes a mean-reversion trade on ARR momentum. If you're with Raymond James, you wait for execution proof. The 50% run-up since mid-April was the setup for the fade – now we see if the floor holds.
Verdict: This is the print of the year. DELL didn't just beat — it obliterated. $43.8B in revenue (24% above UBS est), EPS of $4.86 (68% above consensus). The AI server narrative went from "interesting" to "the whole damn show" in one quarter. Street PTs exploding from a prior $167-$280 cluster to a new range of $440-$700. The old range is dead. New floor is $440 (UBS, Neutral). Ceiling is $700 (Susquehanna, upgraded to Positive).
7 of 8 analysts raised PTs (UBS held Neutral but still raised). Consensus PT now ~$500, but the bull camp ($550-$700) is gaining traction. The key line from Susquehanna: "AI servers now >1/3 of revenue, projected $60B in FY27, up 145% YoY." That's the spine of the bull case. JPMorgan went to 25x P/E from high-teens, citing "improved visibility into higher sustainable earnings growth." Barclays $550, Melius $565 — both citing strength across ALL segments, not just AI.
The only holdout? UBS at Neutral/$440, warning about "demand pull-in" and second-half margin reversion. But even they admit: "AI server revenue $16.1B vs our $13B est" — a massive beat.
"Dell's scale, product mix, and services business...are offsetting AI server gross margin dilution. The company has gained roughly 600 bps of market share as enterprise customers skip the 15th-gen servers." — Susquehanna
The bull case is simple: AI server revenue growing 143% to ~$60B, backlog at $51B, orders of $24B in the quarter alone. And it's not just AI — traditional server revenue grew 92% YoY (supply-constrained, not demand-constrained). Storage accelerated to 8.5% growth, helped by Dell IP attach. PC business printed 17% revenue growth at 9.7% operating margin vs 7.7% consensus. Melius highlights: "beat every line in our model."
The bulls believe supply is the only governor — if allocations improve, estimates go higher. Evercore explicitly: "upside to forward estimates if Dell gets better allocations." Valuation? PEG ratio of 0.97 on $17.90 FY27 EPS. Even at $500, that's ~28x — but JPMorgan argues 25x is justified given growth durability.
"We project second-half EPS of $8.24 vs first-half $9.66, citing expected CSG margin reversion and supply chain constraints." — UBS
The bear case isn't that DELL is bad — it's that the rate of change decelerates sharply in 2H. Guidance implies ~10% sequential revenue decline H2 vs H1 ($82-85B H1, ~$83B H2 at midpoint). That's a $10B drop. Bears point to pull-forward from price increases and component shortages — customers buying early to lock in supply. UBS maintains Neutral because "the market is using $17.90 supply-impacted guidance as baseline" — meaning no cushion for beat-and-raise in FY28.
Valuation is also a concern. After a 183% YoY run and 154% YTD, the stock is not cheap on current earnings. At $317, it's 18x forward EPS — but the bull PT of $700 implies 39x on the same number. That requires a lot of faith in sustained 50%+ revenue growth.
DELL's print is a macro signal for the whole AI infrastructure trade. The $60B AI server target, $51B backlog — these numbers crush HPE and SMCI comparables. HPE up 3-5% in sympathy. SMCI up. The message: enterprise AI adoption is accelerating, not peaking. Supply chain constraints are real but temporary — the demand is there.
But there's nuance. DELL's mix shift is dilutive to gross margins (down 240bps QoQ) even though they beat on GM% consensus. The bears will argue the margin trough is still ahead. And the second-half sequential decline is real — even if "conservative" per management. The key metric to watch: backlog conversion pace and whether Rubin (Nvidia's next platform) in early CY27 creates another backlog wave.
Cortex AI is real. CoCo is the catalyst you’ve been waiting for. The Q1 print was a genuine inflection point — the biggest beat in six quarters, highest growth in eight, and a guided FY product revenue raise of ~400bps to 31%. The narrative has shifted from "when does AI monetize?" to "how fast does it scale?"
The street is consolidating around a $270-320 PT range (Truist $275, KeyBanc/Scotiabank $285, HSBC $289, Cantor $282, Piper $295, TD Cowen/Benchmark $300, Monness $320). Consensus is Buy/Overweight across the board. The old $200-255 cluster is dead.
Product revenue of $1.334B (+33.9% YoY) beat by 5.3%. Operating income beat by 35.2%. Record sequential dollar growth — ever. NRR ticked up 100bps QoQ to 126%. Million-dollar-plus customers up 28.8% to 779. AI accounts grew 45.5% sequentially to 13,600+. The CoCo launch in February has already scaled to 7,100+ accounts and is the #1 driver of the FY guidance raise. Core platform consumption is accelerating because customers are moving workloads to Snowflake to support governed AI use cases. This is the flywheel.
New/incremental:
Bull case: This is a step-change, not a re-rate. CoCo is proving AI can be a consumption accelerant, not just a line item. The 400bps product revenue guide raise is conservative relative to the consumption trajectory. Management's "agentic control plane" vision — connecting data, models, and workflows — is the right endgame. With $6B in AWS partnership muscle and Natoma, they're building the rail for enterprise AI workloads. The 126% NRR with accelerating gross adds suggests the platform stickiness is increasing, not decaying.
"The developments mark a step change in the AI narrative for the company." — TD Cowen
Bear case: Valuation is still rich at 13x EV/CY27 sales — back to the 1-year median. RPO and billings were weaker, suggesting customers are still hesitant to lock in long-term commitments. Competition from Databricks, Google BigQuery, and the hyperscalers isn't static. The AI revenue is real but still small as a percentage of total. Snowflake has historically traded at a premium and gotten punished when growth decelerates — a single quarter doesn't prove the trend is durable. And the $1.94 EPS forecast assumes margins continue expanding against a backdrop of AI investment spending.
Verdict: Identity security is boring until it’s not. OKTA just delivered a quarter that makes the re-rating narrative real. cRPO beat by ~200bps, guide accelerated, and AI agent pipeline is a real call option. Stock gapped +8% above prior 52wk high — the street is scrambling to catch up.
The Quarter in One Paragraph: Q1 cRPO grew 12.2% y/y (vs 10% guide/consensus). Q2 guide implies 11% y/y — another beat baked in. Full-year revenue guide raised by more than the Q1 beat (operating income guide raised by less — they’re reinvesting). Net revenue retention re-accelerated to 107%. Newer products (Identity Governance, Auth0) drove 25% of bookings. AI Agents pipeline is “strong” with early deal activity and larger average deal sizes. 77% gross margins. No zombie legacy here.
The Street Bends: 5 firms raised PTs in a tight cluster — $110 to $130 (DA Davidson $130 Neutral, Cantor $125 Overweight, Jefferies $120 Buy, Stifel $120 Buy, Mizuho $110 Outperform). Consensus is Buy-ish with one Neutral holdout. Everyone is pointing at the same data: cRPO beat, guide raise, AI optionality.
Bull Case (and it's winning): OKTA is transitioning from a single-product access vendor to a full identity security platform. OIG and Auth0 are producing. AI agents are real — early pipeline is material, deal sizes are bigger, and it’s additive to 2028 estimates. At 4.8x EV/CY27 revenue (Jefferies’ math), the multiple has room to expand as growth re-accelerates. Management executed on sales productivity and new rep capacity — cRPO guidance implies another sequential improvement. The bull says the compound effect of identity + AI is underappreciated.
"The firm said it believes this factor [AI Agents], along with continued sales productivity improvements, meaningful new sales capacity ramping toward full productivity, and improving OIG traction, will lead to current remaining performance obligations growth acceleration." — DA Davidson
Bear Case (thin but worth noting): The Neutral vote at DA Davidson says "I need to see it before I believe it." AI agent products are not yet revenue-material. Management’s guide assumes “minimal contribution” from agentic tech. If the macro softens, enterprise identity spend is the first to get pushed. Also, competition from Microsoft (Entra ID) and CyberArk in adjacent spaces remains a long-term threat. The bull case relies on a fairly perfect execution cadence — any stumble and the re-rating unwinds.
"While AI agent products are not yet material to revenue, the size of the pipeline and early deal activity suggest the opportunity could become a more meaningful growth driver sooner than previously expected." — Cantor Fitzgerald
OKTA is the canary in the identity platform coal mine. If they can sustain 12%+ cRPO growth while layering in a new product cycle (AI agents), it’s a template for how legacy cybersecurity vendors re-rate. Read-through: CYBR (identity governance exposure), PING (if they ever execute), and even MSFT’s Entra suite trajectory. But the cleaner comp is ESTC or MDB on the platform-land-grab narrative — except OKTA has higher margins and better cash flow conversion right now.
Key number to watch next quarter: cRPO growth trajectory. If they print 13% (Jefferies’ typical beat assumption), the stock will break out again. If it prints ~11% inline, bears will call peak momentum. Position: crowded long post-gap, but the fundamental setup is the best we’ve seen from OKTA in 18 months.
Verdict: Ambarella is a story of positioning vs. timing. The edge AI thesis is strengthening (Hanwha LTA, 15 robotics wins, 46M SoCs shipped), but the stock is pricing it in — up ~50% over the past year and trading just 5% off the 52-week high. The bull case is compelling but not cheap, and Summit’s H2 supply chain downgrade adds a real overhang. This is a r/r call on execution against a $800M backlog, not on narrative.
PTs range from $96 (BofA, Neutral) to $120 (Rosenblatt, Buy), with Stifel at $106 and Northland at $101. One downgrade (Summit → Hold) vs. four Buy/Outperform ratings. The consensus is constructive but not euphoric — the median target of ~$103 implies ~12% upside from $91.84. No one is screaming cheap.
BULL: The Hanwha deal — $800M over 10 years — is the kind of anchor customer that validates the platform approach. Ambarella is not just selling chips; it’s selling an integrated edge AI stack (200+ AI models, 12 SoCs up to hundreds of TOPS). Management says robotics pipeline has >30 customers, with lifetime revenue >$100M from 15 design wins already. Rosenblatt’s punchline: “Applications for using AI models at the network edge is driving demand.” The shift from training to inferencing at the edge is real, and AMBA is a pure-play merchant SoC supplier at a time when hyperscalers are bringing designs in-house — paradoxically, that complexity is driving companies back to merchants like AMBA.
BEAR: The stock already reflects the good news. FY rev growth guided 10-15% — solid but not explosive. The $800M Hanwha LTA is back-end loaded; BofA notes larger volumes are “more than one year away.” Summit’s downgrade flags supply chain tightening and inflationary pressure in H2 2026 that could “indirectly pressure customer orders.” The company is unprofitable on a GAAP basis (-$1.62 EPS LTM) and trades at a revenue multiple that’s rich for a semi company that’s not yet consistently printing positive FCF. Risk/reward is no longer favorable near the high.
“Hanwha Group and Ambarella have signed a long-term agreement for multiple AI SoC platforms worth $800 million over 10 years.” — Rosenblatt
“Risk-reward profile into the second half of 2026 is no longer favorable.” — Summit Insights (Kinngai Chan)
“Management credited securing long-term agreements with customers and working to reduce DRAM requirements while enabling multi-sourcing.” — Summit (acknowledging mitigation efforts)
AMBA is a bellwether for the edge infrastructure theme — not just robotics but security cameras, telematics, and industrial IoT. The Hanwha deal (a $60B Korean conglomerate) is a signal that large enterprises are committing to merchant edge AI SoCs rather than building in-house. This creates read-through to other semi companies with edge AI exposure: NVIDIA (Jetson), NXP, STM, INTC (Mobileye), and MRVL (though MRVL is more data center centric). The bear case — supply chain tightening — is a sector-wide concern for H2. If AMBA can deliver against the LTA pipeline, it becomes a de-risked compounder. If not, the multiple compresses. Right now the market is pricing in the former, but the strong overlap between PTs and current price suggests limited near-term alpha unless something changes.
Verdict: Cloud revenue print was the story — and it was a bad one. First sequential Q4 decline in cloud. That's the headline. The FY27 guide was actually fine (14.5% cc, above whispers of 13-14%), and RPOs accelerated (28% total, 20% cRPO). But the market hates a decelerating cloud line. The stock is caught between earnest management H2 acceleration talk and the hard data of three quarters of cloud slowdown. This is a "show me" now, not a buy me.
PT range: $55 (TD Cowen) to $85 (UBS). Consensus splits: 2 Buys (UBS, Stifel), 3 Neutral/Holds (TD Cowen, Cantor, DA Davidson). The median sits around $60. The bull camp is banking on the H2 ramp and AI tailwinds. The bear camp is looking at the deceleration and saying "prove it first."
Bull case (UBS $85, Stifel $65): The FY27 guide was a positive surprise — 14.5% cc vs ~13-14% expected. Management explicitly called this a "lowest point of the year" quarter. RPOs accelerated to 28% growth, with multi-year deal activity described as "exceptional." CISA partnership and AI product uptake are real tailwinds. UBS says consensus targets imply 28% upside. Gross margins at 76% offer a structural earnings escalator. The bull argument: once cloud re-accelerates (H2FY27), the multiple re-rates back toward the 3.8x EV/NTM revenue average.
Bear case (TD Cowen $55, Cantor $59, DA Davidson $60): Cloud revenue declined sequentially for the first time ever in a Q4. The SLS beat was only $2M vs a prior $10M beat — the rate of change is slowing. Cantor points to "lack of near-term momentum in SLS" and guided deceleration in FQ1. DA Davidson notes the "lower than typical revenue beat." The bear view: this stock won't re-rate until you see multiple quarters of cloud execution. The "show me" label from UBS (ironically a bull) is telling — even the optimists need proof.
"Elastic has become a 'show me' story. We do not expect the stock to re-rate materially higher until the company delivers several quarters of execution in the cloud business." — UBS
"For the stock to re-rate higher in coming quarters, SaaS results must improve beyond the current focus on Sales-Led Subscription Growth." — Stifel
"Management highlighted sales execution, traction with its CISA partnership, and AI product uptake as tailwinds." — DA Davidson
Observability/search is a crowded AI tailwind story. ESTC is the purest play in enterprise search and observability, competing with Datadog (DDOG), Splunk (now part of Cisco), and New Relic (NR). The cloud deceleration is a company-specific issue — ESTC's cloud transition has been lumpy, while DDOG continues to print 25%+ cloud growth. The narrative tension: AI-driven workload growth is real (CISA, multi-year deals), but the mechanism to capture it (cloud vs SLS) is messy. If ESTC can execute on the H2 ramp, it becomes a compelling margin expansion story. If not, it stays a low-growth value trap at 3x forward revenue. Watch for FQ1 prints — they need to show the cloud line turning.
Verdict: CRM printed a headline beat that pulls victory from the jaws of mediocrity. But nobody's popping champagne. Revenue +11.6% CC beat the 10.8% bogey. Op margins hit 34.8% vs 33.4% consensus. Agentforce ARR crossed $1B — that's the headline they wanted. The problem? 2Q guide implies deceleration in the legacy app franchise, cRPO was "in line" (not ahead) for the second straight quarter, and the AI monetization model is still TBD. Stock is -33% YTD. Valuation is cheap (PEG 0.86). But "cheap" isn't a catalyst.
Beat on revenue and EPS, mostly driven by the ASR ($25B accelerated buyback) and strategic investment gains — not organic acceleration. Agentforce consumption metrics did inflect: active workspace users, tokens, and MCP usage all accelerated QoQ. That's real. But the 2Q guide signals continued headwinds in the core Sales/Service Cloud franchise. Management is banking on H2 acceleration fueled by Agentforce, Data Cloud, and Slack pipelines. The market's response: "Show me."
Price target range is $175 to $290 (DA Davidson at the low end, KeyBanc on the high side). Consensus clusters around $230-250 — a wide spread reflecting genuine divergence on the growth trajectory. 13+ firms cut PTs post-print, but most maintained their ratings. Nobody's throwing in the towel. The collective thesis: Clean quarter, messy guidance, wait for evidence.
"Salesforce opened FY27 with a clean headline beat that defends but does not advance the bull case. With shares already deeply derated, we believe the risk/reward is asymmetric to the upside." — Freedom Broker (PT $230, Buy)
Bull case ($250-290 targets, Outperform/Buy): Valuation is already pricing in a worst-case. At 23x P/E with a PEG of 0.86, you're getting negative premium for a platform generating $13B+ FCF. Agentforce consumption metrics inflected — that's the leading indicator. The $1B ARR crossed in Q1 sets up a second-half acceleration narrative that actually has data behind it. Management reiterated the FY30 Rule-of-50 framework. If even half of the Agentforce pipeline converts, the re-rating is violent.
Bear case ($175-215 targets, Neutral/Underperform): This is a mature app business pretending it's still a growth platform. Organic constant currency growth of 7% is the real number — the 12% headline was inflated by Informatica. cRPO "in line" for two quarters straight. The AI monetization model is still under construction. Nobody can tell you what a "consumption-based AI workload" looks like at scale. And the 2Q guide? Revenue deceleration, flat margins. Bears say H2 acceleration is a "trust me" story from a management team that has over-promised on Agentforce's pace before.
"The second-half outlook is a show-me story. We remain constructive, but investors need visible proof of acceleration." — TD Cowen (PT $240, Buy)
Known: Revenue beat, margin beat, cRPO in line. Agentforce $1B ARR was telegraphed. The buyback impact on EPS was expected.
Incremental:
The -33% YTD decline has discounted most of the bad news. Bears are already in the stock. The question is whether the rate of change in Agentforce consumption can offset the deceleration in the legacy business before next quarter. The stock is pricing in zero AI premium — if the H2 acceleration materializes, you get a re-rating. If it doesn't, you're left with a low-growth SaaS at 23x with a dying core. The asymmetry is real, but it's a timing bet.
Enterprise AI monetization: CRM is the canary. If Agentforce can't convert consumption into durable ARR acceleration, it's a bad sign for every enterprise software name pushing AI agents (think NOW, ADBE, MSFT Copilot). The consumption model vs subscription model debate is the meta-theme here. CRM trying to bridge both — and the market isn't buying it yet.
Peer comps:
Verdict: The AI infrastructure narrative is intact, but the stock has already priced in a lot of the multi-year visibility. The post-print squish (initially green, then -3%) tells you everything — the guide was fine, the framework was huge, but the entry is now $200 after a 134% 1-year run. PMs are wrestling with how much of that $16.5B FY28 revenue target is already in the tape.
Analyst collective: 6+ firms raised targets to a new cluster of $200-$275, from prior $130-$190. TD Cowen (Hold, $200) cites networking as the dollar-growth driver through FY28. Cantor (Neutral, $220) flags the 29x FY27 P/E vs NVDA/AVGO at 14x/17x — “better upside elsewhere.” Benchmark (Buy, $275) is the outlier bull, doubling his target from $130, and he’s the one writing the most detailed piece on the ramp.
The real signal is the unusually detailed ramp commentary across interconnect, switching, custom silicon, AECs, retimers, DCI, and scale-up optics. That’s not typical management language. They’re laying out the map.
Benchmark (Cody Acree): “The central institutional debate is how much of Marvell’s $16.5 billion fiscal 2028 revenue framework and fiscal 2029 custom-silicon target is already embedded in the share price, and how much value investors should assign to scale-up switching and newer optical programs that management still views as mostly in front of the model.”
The $16.5B FY28 framework is a floor, not a ceiling. Street 2028 EPS consensus is ~$7.65, but a subset of investors is modeling $10-12+, and Cantor explicitly acknowledges that. The PEG of 0.16 (Benchmark) suggests the multiple compresses on growth. This is an AI compounder — interconnect, custom XPU, optics — all secular, all multi-year. If the second-wave AI spending cycle accelerates, MRVL is the purest play on the physical layer.
You’re paying 65x trailing earnings for a stock that just put up a mostly in-line quarter. The valuation argument from Cantor is hard to ignore: NVDA and AVGO trade at half the multiple with larger total addressable markets. The custom XPU visibility is still “challenging,” per TD Cowen. And the stock has already run 26% in the last month alone — the easy money was made before the print. The post-earnings digestion tells you the buy-the-rumor crowd is now selling the news, even with a $275 PT out there.
Mixed quarter, but billings miss keeps us on the sidelines. Revenue beat, EPS crushed, guidance tweaked up — but the forward-looking metrics tell a different story. Stock trades at ~$7.35, well below the $8-9 targets from the two neutral shops, and far from Citizens' $15 bull case. Not ready to put capital to work.
$205M REV (9.5% y/y, ~1ppt beat), EPS $0.10 vs $0.07 consensus — that's a 42% beat. Non-GAAP op margin popped to 11.5% from 8.8% q/q. Gross margins held at 88.5%. Net dollar retention ticked up to 97% (gross retention improving, expansions in AI and seats). Tech vertical returned to growth for the first time in eight quarters. FY27 organic revenue guide bumped to 8.0% constant currency from 7.8% — basically just flowing through the Q1 beat. But billings came in at $194M vs $204M consensus. RPO $518M vs $526M. The beat was rearview. The billings miss is the headlight.
Bull (Citizens): AI is real here. StackAI acquisition adds non-seat-based revenue potential. Tech vertical inflecting + gross retention improving = durable reacceleration. PT $15 implies 100%+ upside from current levels.
Bear (UBS, D.A. Davidson): Budget pressure on applications IT, hiring uncertainty, and billings miss signal deceleration ahead. Guidance leaves only 40bps of buffer vs Q1 run-rate. Product-led growth headwind of ~2ppt ARR still embedded. Neutral PTs $8 — barely above the tape.
"The business is still navigating multiple headwinds in its return to more durable growth." — D.A. Davidson
That's the honest read. Revenue beat is nice, but billings miss and muted guide (despite the beat) tell us the rate of change hasn't flipped yet. Cash burn? Not awful — they've got ~$550M in cash and no debt — but this isn't a growth re-rate until we see billings inflect.
ASAN is a show-me story. The tech vertical green shoot is interesting (first growth in two years). AI monetization via StackAI is a real optionality. But macro headwinds to app budgets aren't going away overnight. Until billings stabilize and guide implies acceleration, we're watching from the bleachers. The risk/reward isn't compelling enough at $7.35 — you'd need to believe in a V-shaped recovery to chase it, and the data doesn't support that yet. Leave it for the event-driven guys if a takeout (PE?) ever materializes.
Verdict: Two new revenue streams that could shift the narrative away from pure ad dependency. Checkout partnership with Stripe and the enterprise AI push both add optionality – but execution risk is real. Market cap already $1.61T, P/E 23x, gross margins 81.9%. Analysts like the direction, but you need to watch the pace.
Citizens keeps Market Outperform / $825 PT. The thesis: Meta is relaunching on-platform checkout via Stripe’s Agentic Commerce Suite. Users tap saved credentials, 2-step purchase. Early look? “Experience is similar to the retired Facebook and Instagram Shops user experience” – so they're basically trying again after the first attempt fizzled.
“Merchant pushback is expected as building a basket appears challenging and merchants typically want direct connections to consumers.” — Citizens
The trade-off is data. Meta wants the attribution from on-platform sales. The new Universal Checkout Platform includes subscription and loyalty features that the old one lacked. If they get product tagging scaled across content, this could actually stick. 5 analysts revised earnings up recently. Revenue growth 26% – not priced for a re-acceleration, but the checkout initiative adds a TAM they didn't have.
BofA reiterates Buy / $835 PT. Meta just set up a new Enterprise Solutions unit – customizing AI tools for corporate clients, building repeatable deployment models. CEO hinted at cloud computing if infra investment yields excess capacity. Inbound demand for APIs and compute is already strong.
“Enterprise AI solutions… an opportunity to introduce a more durable, less macro-sensitive monetization stream.” — BofA
Enterprise AI + cloud capacity market expected to top $1T by 2028. BofA flags capacity overbuild as a risk – if Meta builds too much, pricing and margins get squeezed. But with $1.6T market cap, even a slice of that TAM moves the needle. Rosenblatt is even more bullish at $1,015 PT, leaning into the subscription pivot (Meta One for Instagram, Facebook, WhatsApp – separate news).
Bull case: META is adding two high-margin, recurring revenue streams (enterprise AI + checkout) on top of a still-growing ad business. The infrastructure spend is a moat, not a cost. P/E 23x for a company that could compound at 15-20% – cheap.
Bear case: Merchant pushback kills checkout (again). Enterprise AI faces fierce competition from hyperscalers (AWS, Azure) and META lacks enterprise sales DNA. Capacity overbuild leads to margin compression. Subscription roll-out could cannibalize ad revenue or alienate users.
Bottom line: The optionality is real, but neither thesis is derisked. META is a show-me story until we see merchant adoption and enterprise traction. At $635, it's not pricing in any of this – which is the opportunity or the trap, depending on your time horizon.
Verdict: MOD is pricing in perfection but the $4B deal gives them cover. 2 analyst upgrades post-Q4 beat, PTs now $330-355. The narrative is pure data center momentum — and the street is still playing catch-up.
MOD YTD +103%, 1-year +196%. P/E of 124x tells you the multiple is already pricing a decade of growth. But with a $4B long-term agreement through 2029, you’ve got a revenue visibility that most datacenter plays would kill for. The question isn’t whether MOD can grow — it’s whether the rate of change accelerates fast enough to justify the multiple.
Q4 FY26 crushed — EPS $1.71 vs $1.57 consensus, revenue $954M vs $921M. That’s an 8.9% beat on the bottom line. The real catalyst: the $4B datacenter agreement announced alongside earnings. That’s a multi-year framework that gives management the confidence to guide up.
One hiccup — component shortages hitting chiller volumes in FQ1. DA Davidson flags it. But MOD is qualifying new vendors, which should recover volumes through the year. Net-net: a near-term speed bump, not a structural issue.
Two upgrades, both Buy, both raising PTs off the same catalyst:
"Combination of expected forecast revisions and what UBS views as a relatively low valuation signals potential upside to the current share price." — Neal Burk, UBS
MOD is a datacenter play with a product cycle that’s very much in the early innings. The $4B deal is a hammer — it turns a speculative compounder into a visible compounder. That’s why the PTs keep climbing. The risk is multiple compression if growth decelerates, but the rate of change is still positive and likely to accelerate as Q1 shortages clear.
I’d keep exposure long, but wouldn’t be adding at these levels unless you have conviction in FY28+ earnings doubling. The stock has already run hard. Let the Q1 print tell you if the component issue is real or just noise.
Verdict: Revenue beat, EPS miss, and the analyst crowd still can’t get comfortable. Two notes out this morning – one from DA Davidson (Neutral, PT to $12 from $13) and one from BofA (Underperform, PT to $13 from $12). Net effect? A push. PTs now bracket the stock at $11.58, so the path forward is a debate about whether execution can overcome structural skepticism.
Q1 FY27 was a classic PATH print: REVENUE $418M VS ESTIMATE $397M (BEAT BY 5.3%), but EPS of $0.15 missed the $0.16 bogey by 6.25%. Gross margins at 83% remain a highlight. ARR growth came in ahead of guidance, and the company guided better than feared. That’s the good news. The bad? The top-line beat masks a still-sub-15% revenue growth rate – 10% for CY27 per BofA – and a narrative that RPA is being disrupted by the same AI wave they’re trying to ride.
Both firms acknowledge execution improved. DA Davidson raised estimates modestly, BofA upped its multiple from 2.6x to 2.8x EV/CY27 revenue. But neither is buying the story at current levels. DA: "growth is adequately priced in today as traction with new AI products remains early." BofA slaps a 2.8x multiple (vs infra software peers at 5.3x) saying the discount is warranted given "questions around long-term durability of UiPath's value proposition in a rapidly evolving AI landscape."
"We believe growth is adequately priced in today as traction with new AI products remains early in providing more significant upside to revenue." — DA Davidson
This is a show-me story trading at a show-me multiple. The revenue beat is real, but the AI product cycle is still more vapor than velocity. Until PATH demonstrates that new offerings are re-accelerating top-line growth (not just maintaining), the market will keep the discount. For PMs: a potential mean-reversion trade if Q2 guidance surprises, but don't expect the multiple to expand until the narrative shifts from "AI disrupts RPA" to "AI supercharges RPA." That day isn't here yet.
Verdict: Storage is back, baby. NTAP printed a monster quarter that blew away bogies on revenue, margins, and EPS. The two analyst calls tell the whole story — UBS lifting PT to $160 (Neutral, cautious on margin compression) vs Barclays going nuclear to $199 (Overweight, full-throated conviction). The stock is up 34% YTD and trading near its 52-week high of $143.65. The debate is whether the margin story has legs or if Q1 guidance signals mean reversion.
Revenue $1.95B — 2% above UBS’s $1.91B bogey, 4% above consensus $1.87B. EPS $2.43 vs guide of $2.21-2.31 and UBS est of $2.26. Gross margin 70.5% vs UBS est 70.0%. All-flash revenue $1.22B, +18% YoY. No material pull-in or pricing noise — demand was legit. Public Cloud (ex-Spot) grew high-teens. NTAP guided FY27 core storage product revenue up high-single digits. The beat was clean.
This is where the bull/bear split lives.
Barclays ($199 PT, Overweight): Sees the beat as confirmation of a structural shift. Product margins rebounded hard after a Q3 miss. Public Cloud margin expansion accelerating. They think NTAP is gaining share in all-flash and the mix shift toward high-margin support revenue is durable.
"NetApp delivered results that beat expectations on both top and bottom lines. The company’s margin performance was a key driver of the price target increase."
UBS ($160 PT, Neutral): Acknowledges the beat but flags margin headwinds. They model Q1 FY27 product gross margin below 53%, total gross margin in the mid-69% range. Full-year gross margin ~69.2% — down ~200bps YoY. They think the 70.5% print is a peak, not a new plateau.
Bull case: All-flash is a multi-year replacement cycle tailwind. NTAP’s public cloud strategy (high-teens growth, margin expanding) diversifies away from pure hardware. Free cash flow conversion is strong, and the stock at 32x P/E is reasonable if growth sustains. Barclays sees $199 — that’s 40% upside from here.
Bear case: Product gross margins are coming back to earth. The 70.5% Q4 was aided by timing and mix that won't repeat. UBS sees full-year GM down 200bps. At 32x earnings with mid-single-digit revenue growth, multiple compression is a real risk if margins slip. The 52-week high feels stretched.
NTAP is telling a legitimate all-flash share gain story, but the margin expansion narrative is priced in. Barclays is the outlier on the Street (PT $199 vs consensus ~$150). If you trust the margin beat is structural, buy — if you think Q1 guide is a tell, fade. The stock is not cheap, but it's not obviously wrong either.
VERDICT: Q1 beat + raised guide is the real story here. The MaintainX acquisition is the headline grabber, but the stock got punished anyway (trading near 52-week low of $214, currently $225). Market is pricing in execution risk on the $3.6B deal. We think the selloff is overdone – the core business is trending teens growth, margins hold, and the TAM expansion is real. Not every big M&A bet works, but ADSK has the playbook from Construction.
EPS of $2.99 beat consensus $2.84 by a clean 5%. Revenue of $1.93B also topped the $1.89B bogey. Billings grew 13.5% adjusted constant currency – that's the metric the PMs care about. Guidance got a 0.5-1pp bump for FY27. Gross margins STILL 92%+. This is a machine. RBC and UBS both acknowledge the beat was stronger than feared given the macro noise.
ADSK is buying MaintainX for $3.6B – their biggest deal ever. It goes beyond Design & Make into operations (think maintenance, asset management). UBS says this addresses a "known gap" from customer feedback. The price: UBS estimates a 20x+ EV/S on CY27 sales for a 50% grower. Rich, but ADSK is applying the Construction playbook to operations, which they call "a potentially larger opportunity over time." RBC cut its PT to $305 from $335 to reflect the dilution, but still at Outperform. Net net: the deal is dilutive in FY27 but should be absorbed within FY27-FY29 margin targets.
Blockquote (RBC): "Autodesk remains well positioned to define the next generation of industrial artificial intelligence."
BULL: Q1 execution was clean, guide raised, core growth durable at teens. MaintainX opens a serviceable addressable market bigger than construction. At 46x P/E but with 18% revenue growth and 92% gross margins, the multiple compression is done – stock is near the 52-week low and the risk/reward tilts positive.
BEAR: $3.6B is a lot of chips on a deal still early in its synergy story. 20x+ EV/S for a 50% grower in a choppy macro environment. The stock didn't follow the beat higher – aftermarket slipped. PMs may want to see the next quarter of billings before embracing the narrative. You can get paid to wait for a better entry.
DY IS YOUR FAVORITE TELECOM SERVICES PLAY RIGHT NOW. Two firms raised PTs to $611-$654 from a prior $436-$444 cluster post-Q1. Stock at $535, up 134% in 12 months, 58% YTD. The message: this is not just weather.
Q1 FY27 was a monster. EPS $4.42 vs $2.72 consensus — a 62.5% beat. Revenue $1.965B vs $1.67B (17.4% beat). Both UBS and Cantor raised numbers aggressively, with UBS bumping FY27/28 EBITDA by ~10-13% to $1.1B/$1.27B. Two-thirds of that EBITDA uplift comes from Building Systems (not just comms).
The key debate: was it weather? Management says demand was the real driver — favorable conditions let them execute, but you still need the backlog to pull from. Cantor's note quotes management directly:
"Management said permitting and preparing local projects for construction remains the limiting factor."
That's the bottleneck. Not demand. Not labor. Permitting.
Fiber-to-the-home grew 33% sequentially and was the primary driver of the Communications revenue increase. Competitors are still struggling with execution — DY is taking share.
(Notable: UBS explicitly says NTI deal is NOT in their estimates. That's call optionality if it closes.)
BULL: Structural fiber/5G buildout is multi-year, DY has best-in-class execution, share gains are accelerating, and NTI provides a M&A kicker. Margins are inflecting as mix shifts to higher-value work.
BEAR: Q1 pulled from Q2. Weather was a genuine tailwind that reverses. Permitting delays persist. Input costs could reset if labor tightens again. NTI is a wildcard — if it falls apart, that "optionality" disappears.
BOTTOM LINE: DY is working. FTTH demand is real, share gains are sticky, and the consensus is still playing catch-up on estimates. The 134% move doesn't feel done yet — not when the beat was this clean and the narrative is still migrating from "weather" to "structural."
THE GROWTH STORY IS INTACT. THE MULTIPLE IS NOT. TTAN sits at $65.50, down 29% from post-IPO highs, despite 24.5% revenue growth over the last twelve months. Two analyst notes today, both constructive, both acknowledging the disconnect. Stock needs the June 4 print to show growth re-accelerating — not just holding.
Piper Sandler stayed Overweight, $100 PT. BMO kept Outperform, $92 PT. Both see the same narrative: the Q1 guide of 18.7% y/y growth is a floor, not a ceiling. Low-20% growth is achievable. The bull case rests on three legs: MAX PROGRAM ACCELERATION (revenue-per-customer expansion), HARDI INFLECTION (March hit 10.4% after a downtrend — Piper views this as a GTV proxy), and AI TOOL ADOPTION (new CTO, potential operating leverage). BMO specifically flags usage revenue rebounding after Q4 headwinds.
The analyst consensus is overwhelmingly bullish — Piper, BMO, Stifel, KeyBanc, Needham all Buy-rated — but the average PT of ~$105 implies a stock that's not exactly screaming buy at $65. PTs range $90 (BTIG, citing software multiple compression) to $125 (Stifel). That spread tells you everything: the story works, the comps don't.
Bull: ServiceTitan owns a vertical (trades) with structural tailwinds. The Max program drives wallet share, AI drives margin expansion, and the HARDI re-acceleration signals the GTV growth engine is restarting. This is one of the better enterprise software stories. Low-20% growth at 5x-ish EV/Sales is cheap if they sustain it.
Bear: 29% drawdown isn't random. Growth decelerated from the 30s to the high teens. Multiple compression is real — BTIG pointed to it explicitly. The stock won't re-rate until growth recovery "extends beyond seasonal and calendar factors" (BMO's words). If Q1 is just noise from easy comps, not structural, you're catching a falling knife.
From Piper Sandler:
"ServiceTitan's exposure to the trades continues to make it one of the better stories in enterprise software."
That's the core thesis. Vertical SaaS with high switching costs, recurring revenue, and a TAM that's not dependent on enterprise IT budgets. The question isn't whether the business is good — it's whether the market cares right now. June 4 answers that.
Wolfe doubles down on the supply chain services story – reiterates Outperform, $320 PT. The thesis is straightforward: Amazon is leveraging its logistics infrastructure to attack a $1.2 trillion global addressable market (freight, distribution, shipping), and even low single-digit share gains add to revenue and operating income. The new Amazon Supply Chain Services (launched May 4) offers unified dashboard + consumption pricing for non-Amazon sellers – Amazon Freight (LTL) and Global Logistics (ocean/air) are the headline additions.
"The expansion may take several years to scale, but Amazon can fill excess capacity with non-Amazon sellers while improving its cost profile."
Stock sits at $274 (near 52-week high of $278.56). Wolfe’s $320 implies ~17% upside. Not sure we read much into the 24 upward earnings revisions – that’s momentum, not a catalyst. The real debate: how fast does the $1.2T TAM translate to P&L? Wolfe models low single-digit % gains, which is fine, but PMs should watch whether the freight/fulfillment margin structure compresses Amazon's overall margins near-term. (Also: Berkshire sold the entire AMZN stake – noise, given they sold other tech names, but it’s a headline.)
Take: Susquehanna ripping the PT to $1,750 from $600 is the kind of re-rating that makes PMs check their size. Stock already up 856% in the past year and sitting at $970 — close to $1T market cap. The call isn't just about AI HBM, it's about the entire memory pyramid staying tight through 2027.
Bunch of firms piling on: DA Davidson to $1,500, Mizuho to $1,150, Barclays to $1,175. The collective thesis is supply discipline (KV cache offloading discouraging wafer adds) + sustainable margins. This is a structural re-rate, not a cyclical peak grab.
"Supply is now expected to remain tight through 2027, sustaining elevated margins and thus warranting valuation re-rating."
Bull case: you're buying a de facto oligopoly with AI demand that's not satiated for years. Bear case: you're paying 10x+ book for a commodity memory company that could see demand rollover in a recession. Not sure we can read too much into the $1T milestone — it's a round number, not a fundamental signal — but the rate of change in estimates is real. Watch for any HBM pricing data points at upcoming conferences.
Susquehanna raises PT to $3,250 from $2,000 — the latest in a parade of upgrades for this memory juggernaut. Mizuho just bumped FY’27 revenue to $45.3B (consensus $43.6B), Barclays upgraded to Overweight with a $2,300 PT, and S&P upgraded credit to BB+ given net cash position. The stock is up 4,153% over the past year (trading at $1,669, near 52wk high of $1,698). The crowd is converging on one story: AI inferencing is driving NAND demand, enterprise SSD orders are accelerating into Q3, and supply stays tight through 2027 — sustaining 56% gross margins. The old memory cycle fear is dead. This is structural.
“The memory and storage pyramid continues to evolve, supported by ongoing changes to KV Cache offloading, which has discouraged aggressive memory wafer capacity additions. Supply is now expected to remain tight through 2027, sustaining elevated margins.” — Susquehanna
(Channel inventory note: Taiwan module houses appear to be carrying about a quarter of inventory — not alarming given demand momentum.)
NEUTRAL HOLD — CANTOR SITS ON THE SIDELINES as TXN trades >30x their 2027 FCF vision ($10/share). Stock at $315.95 is 5% above their $300 PT, and they see better r/r elsewhere. But the data center story is the reason you can’t short it either.
The big takeaway from the dinner: Data center hit 12% of revenue in Q1 and is ON TRACK TO SURPASS PERSONAL ELECTRONICS. TAM growing 65% in CY2026, with over half the DC biz in power — specifically leveraged to the 800V transition and stage 2 architectures. Pricing flat Q2, potentially up H2 (price hike letter went out May 7, effective July 1). Lead times stable. Capex/deprec unchanged.
“The total addressable market is growing 65% in calendar year 2026… more than half of the company’s data center business is power-related, with particular leverage to stage 2 and the 800V transition.”
The bull case is gathering steam — Seaport upgraded to Buy, Stifel raised to $340, Mizuho to $300, and BofA named TXN a top pick in AI power semis alongside ADI and ON. All pointing at underappreciated DC power compounding on top of a cyclical auto/industrial recovery.
Stock up 76% in 12 months, kissing $331.52 high. You’re paying for perfection. The data center growth is real, but the setup isn’t clean. Wait for a pullback or a miss on the macro side.
Verdict: Too rich for our blood here. MS reiterates Equalweight at $405 (consensus around $500) even as the stock sits at a COSMIC 360x P/E after a 599% one-year rip. They see CIEN beating by 3-5% with Q3 guide ~$50-75M ahead of Q2, but that's all supply-gated — margins stay capped until 2027. The bull case (TD Cowen at $675, Stifel at $585) rides on AI optical demand; the bear case (Rothschild at $416) says valuation already prices in perfection. Profit-taking is happening, and the June 4 print is a binary coin flip (options imply 13% move either way). Not the r/r we want with that multiple.
"Peer results… pointed to demand ahead of supply and sustained optical and cloud strength. The firm expects Ciena likely beats revenue by 3% to 5%… gated significantly by supply." — Morgan Stanley
The margin story is next year’s problem, and at 36x forward EV/EBITDA (using bull-case numbers) you’re paying for a 2027 margin expansion that hasn’t started yet. Pass.
Still early innings on AI capex, says Cantor. Reiterates Overweight with $575 PT (~28% upside from $451 close). Bull case rests on AMAT's own analysis that Agentic AI + CPU/DRAM expansion is 20% accretive to total WFE spending. Management sees eight-quarter order book visibility and conversations stretching beyond 24 months — not a demand cycle hitting a wall.
The stock has delivered a 179% RETURN over the past year, currently near its 52-week high at $462.40. Cantor kept it a top pick. The EPIC center co-innovation push is the structural hook: get designed into next-gen product cycles earlier, lock in revenue share. AGS segment getting AI-driven efficiency gains too (more revenue per tool, long-term guide raised).
Consensus across Mizuho ($540 PT), TD Cowen ($525), Lynx ($540) tells the same story — AI logic and DRAM fab expansion, strong packaging share. No bear case in this note. The real debate for PMs: how much of a $180-200B WFE run-rate is already discounted at these levels.
"Management believes the company remains in early stages of the AI trade, with AI driving compute demand and innovation focused on materials and full-system solutions." — Cantor Fitzgerald
Jefferies raised PT to $300 from $265, keeps Buy — but warns shares are “range-bound” near-term unless organic net new ARR blows out. Stock already up 66% since April 10, trading $257.77, 1% off 52-week high. PT implies 37x FCF — not cheap, but they have growing conviction on AI-driven catalysts (observability, identity) pushing FY28 FCF past $6.4B.
“Shares are range-bound in the near term unless organic net new annual recurring revenue materially exceeds expectations and organic services revenue stabilizes or accelerates versus the fiscal second quarter’s 13% year-over-year growth.”
Earnings June 2 — options market pricing an 8% move either way. Benchmark raised to $270 (Buy) on expectation PANW beats on NGS ARR, revenue, OI, FCF. UBS remains Neutral at $183 (valuation). Guggenheim also Neutral — sees NGS ARR upside from M&A but limited total revenue risk/reward.
Bigger picture: 40% YTD return, trading near all-time highs, and the bar is high. Bulls need a clean beat AND a guide-up that validates the AI pipeline. Bears say valuation already priced in. We’ll know in four days.
Verdict: Risk/reward tilts to the upside into Computex. Lynx Equity finally flips from a year-long cautious stance, calling the Sunday night keynote a potential catalyst to shake off the post-earnings drift. The stock has lagged peers while other AI semis hit new highs — but at a P/E of 32.78x and a PEG of 0.29, the valuation argument is hard to ignore.
The firm expects Jensen to directly address the recent underperformance, lay out the $20B revenue / $200B TAM narrative for Agentic AI CPUs, detail the Rubin ramp within the $1T GPU AI systems outlook, and provide a networking segment roadmap. The key hang-up has been hyperscaler ASIC competition depressing the multiple — Lynx thinks the CEO can make the case for coexistence.
“The CEO has an opportunity to make the case that the AI market is large enough for multiple solutions to coexist.”
Near-term setup matters. The "trillion yuan feast" dinner with Foxconn, TSMC, and other supply chain titans signals broad ecosystem alignment. We’re not sure this alone reverses the tape, but the risk/reward is asymmetric for a name that’s been dead money vs. peers. Watch for any incremental Rubin timing detail or a surprise networking update that could re-rate the stock.
RBC goes to $250 from $219, Outperform. They met with management and came away convinced DDOG is the best way to play the observability spending cycle. Cloud migration + AI adoption = more logs, traces, metrics to monitor. New products are adding incremental juice. Not a surprise DDOG is the "top growth idea" here — the Q1 print was a beast: 32% REVENUE GROWTH, 4.8% beat vs consensus, strongest in nearly four years. FedRAMP High certification gives them federal workload access too.
"Datadog remains a top growth idea following a meeting with management." — RBC Capital
Multiple firms followed the print: Benchmark to $230, Rosenblatt to $220 (both Buy), Truist to $190 (Hold). The PT cluster is widening but the narrative is consistent — AI workloads are real and DDOG is the pick-and-shovel. (Not getting carried away on that $250 ceiling; peers have expanded, so RBC is just keeping pace.)
JEFFERIES THROWS A 55% PT HIKE INTO THE AI NARRATIVE — $775 FROM $500 — and CRWD is already knocking on $677 (52-week high). Stock up 43% YTD, now trading 24x CY27 revenue. Bar is high. Need Q1 net new ARR of ~$275M AND FY27 guidance that signals re-acceleration into 2H.
The AI positioning is the real story here. Jefferies sees CRWD as the prime beneficiary of AI-driven security wallet expansion — not just endpoint share gains. That’s what justifies the multiple.
"CrowdStrike continues to be in pole position for the AI race" — Analyst Joseph Gallo
Expectations have run ahead of reality a bit (stock +43% YTD before the print). Near-term upside capped unless the guide delivers ARR growth acceleration into 2H. Benchmark also pumping the stock to $700 ahead of the June 3 print, expecting a beat. Guggenheim sits Neutral — valuation is the bogey, not the thesis. Moody’s upgrade to Baa2 adds a credit quality tailwind but won’t move the tape.
Bull case: AI tailwind is structural, not cyclical. Bear case: multiple already reflects perfection. We’ll know more June 3.
Verdict: Best-positioned materials name in the extending WFE upcycle. Mizuho bumps PT to $180 (from $175) — not a massive move, but the direction matters more than the magnitude here. They're raising 2026/2027 WFE estimates by 10-20% on AI logic and memory fab buildout, and Entegris is the purest consumables proxy. Every incremental tool installed = recurring high-margin revenue.
"Entegris is among the best-positioned materials names in an extending wafer fabrication equipment upcycle."
Stock already up 92% in the past year (trades $138), so this is a "we're not done" signal from a shop that raised its own macro assumptions. The asset-lite, consumables model means ENTG compounds with industry capex, not just one-time installs. Not a breakout trade today, but the narrative is getting longer — not shorter.
Verdict: Still a buy. RBC’s Swanson keeps Outperform, $300 PT. The near-term catalyst is Project Lightwell — an AI security layer for open-source software that hits exactly where the enterprise fear is right now. Anthropic’s Mythos Preview found nearly 3,900 high-severity vulns in open-source code. IBM’s one of the biggest OSS enablers in the world, so they’ve got both the incentive and the balance sheet to own this defense narrative. Revenue growing 10%, PEG at 0.24 — the valuation hasn’t caught up to the repositioning.
“Project Lightwell is consistent with IBM’s broader positioning as a leader in open-source enterprise software enablement.” — Matthew Swanson, RBC Capital
Side note: The Chips Act $1B for quantum + the new Anderson foundry is real structural capex, not a near-term P&L swing. But it keeps the long-duration narrative alive for PMs with a multi-year horizon. Swanson didn’t adjust the PT, so this is more about conviction maintenance than a new edge. Still, at 12x forward earnings with that growth rate, the trade works if AI adoption accelerates.
First real coverage flag on AUR this morning — Northland initiates Outperform, $11 PT (55% upside from $7.07). Thesis: AI models (OpenAI o1) are unlocking physical agentic AI, and Aurora is the pure-play autonomous trucking leader deploying 200 drivers this year. Revenue growth >400% baked into the story. The Q1 EPS beat (-$0.10 vs -$0.11) adds a small operational tailwind, but the narrative is all about scale and positioning.
"We see demand as almost unlimited with few competitors due to the difficult technology challenge involved in autonomous driving."
Northland expects exponential growth in physical agentic AI in 2026+. AUR already up 84% YTD — this initiation gives the bull case a stamp of credibility, but at $7 it’s still pricing in a lot of execution risk.
Barclays stays Equalweight / $49 on Viasat after the FQ4 print and FY27 guide. The stock is up 835% in twelve months – now trading at $87, well above that $49 target. Revenue missed Street consensus by 2.4%, adjusted EBITDA missed by 3.5%, and FCF of $24M was a third of what Barclays modeled. But EPS of -$0.02 beat the -$0.43 estimate (on a loss, so less impressive). Net debt is still $4.8B. Guidance calls for mid-single digit revenue growth and flat-to-slightly-higher EBITDA, back-end loaded, with CapEx nearly a billion. Defense grew 12%, Comms shrank 2%. Maritime stabilizes by end-2027, Equatys D2D not until 2029.
"The platform’s Fair Value analysis suggests the stock may be overvalued at current levels."
Verdict: The massive run has priced in a turnaround that hasn't fully materialized. Revenue and EBITDA are still grinding, FCF is weak, and the balance sheet is heavy. The bull case rests on Defense momentum + D2D optionality years out. The bear case is that the multiple has already swallowed that optionality. Barclays isn't buying the rally – and they run a $49 target for a reason.
CRAIG-HALLUM CUTS PT TO $42 FROM $48, STAYS BUY — but that price target still implies 31% upside from $32. The stock got torched -34% in a week after a Q2 miss ($0.42 vs $0.53 consensus, revenue $209.9M vs $216.7M) and weak Q3 guide ($207-215M vs $218.5M). Near-term headwinds are real: IC softness from high fab utilization, memory supply constraints, and geopolitical delays on design releases. Yet management flags tape-out recovery starting in May.
"Management noted early signs of tape-out recovery beginning in May."
The bull case rests on two structural catalysts. First, the Allen, Texas facility is in qualification — initial revenue targeted late FY2026, with meaningful contribution from advanced node work in 2027 after they migrate mainstream out of Boise. Second, FPD business just printed one of its strongest quarters ever at $62M (+13% YoY), driven by AMOLED in China and Korea reacceleration. They installed the world's most advanced FPD mask writer (first of its kind deployed). Valuation is cheap: 16x FY2027 EPS of $1.98 plus ~$11 net cash per share. P/E on trailing is under 12x. For a photomask duopoly player with a catalyst path in 2026/27, the risk/reward skews positive — but the near-term tape is horrid and you'll need patience.
Pipeline headline noise hit the tape, but don't overreact. BMO reiterated Market Perform / $279, noting third-party analysis that the Green Chile lateral to Oracle's Project Jupiter may not qualify for FERC blanket certificate. Key line: "currently expects no impact to Bloom Energy’s 2026 guidance despite the pipeline concerns." The stock sits at $275.62 after a 1,462% GAIN in the past year. The real thesis remains intact: Oracle's 2.45 GW of Bloom fuel cells is in motion, and the guidance raise post-Q1 is still fresh.
"BMO Capital stated it currently expects no impact to Bloom Energy’s 2026 guidance despite the pipeline concerns."
The broader analyst community already priced in the demand wave. In the past month: Barclays to $254 (Equalweight), BTIG to $295, TD Cowen to $235, Roth/MKM to $225, Evercore to $295 — all citing data center tailwinds and the Oracle partnership. One FERC snag on a lateral pipe doesn't crack the supercycle thesis. Watch the stock for dips into the $250s as potential entry points, but don't chase the headline panic.
Verdict: RBC is right to flag the stabilization, but $9 PT still screams "dead money" for this 54% y/y loser.
RBC lifted PT to $9 from $8 (Sector Perform) after management finally stopped the bleeding. The Q1 beat helps: EPS $0.32 vs $0.25 consensus, revenue $121M vs $119.5M. Gross margin at 85.1% is elite. But the stock is $7.44 — barely 2.5x that PT. The story is "less bad," not "getting good."
The real debate is whether the shift to consumption-based pricing and Operations Cloud can re-accelerate revenue growth above the low single digits. RBC sees early signs of seat-downsell mitigation and wallet expansion, but no one is pounding the table yet.
"Management’s performance in stabilizing the company at the start of the fiscal year creates opportunities for growth throughout FY27."
Sure. But opportunity != catalyst. This is a show-me story trading at a discount to net cash. For PMs: fine for a small distressed turnaround bet, but don't confuse low expectations with a re-rate.
JPMorgan pulls the trigger to Neutral from Overweight post data center sale — the catalyst trade is done. Stock ripped 21% since the May 5 update (S&P +5%), but that move already prices in the $225M DC sale to I Squared Capital. Now back to the grind: core operating trends and a balance sheet that still has a $2.66B debt tower against a $947M market cap.
"The data center sale catalyst is now behind the company" — JPMorgan's Sebastiano Petti
PT stays at $22 (9.6x 2027 EV/EBITDA vs 9.3x current). Net leverage improves to 6.6x exiting 2026 from 7.4x, but that's still a long way from CEO Schaeffer's 4.0x target. The stock is down 57% over the past year for a reason — revenue missed Q1 ($239.2M vs $241.3M), EPS beat on cost cuts (-$0.83 vs -$1.00). Light coverage, but the r/r after the pop looks neutral at best.
Verdict: battleground stock with a long tail POS narrative that UBS thinks is underappreciated — but the 32.8% drawdown over six months tells you the market isn't paying for that optionality yet. UBS reiterates Neutral, $130 target (stock at $110.32). The POS piece is real: 12% of GMV today, could be 20% by 2035, contributing 300-500bps to the 10-year GMV CAGR. That's not nothing, but it's a decade out. Meanwhile the rest of the analyst community is split — RBC Outperform at $170, Piper and KeyBanc both Overweight at $150-160, but Cantor just cut to $115 on margin concerns. Thrive Capital's $100M AI bet adds narrative juice, but the stock is still bleeding.
"Shopify's Retail POS business represents an important part of the longer-term growth algorithm and a relatively underappreciated portion of the company's terminal value."
That's the bull case in a single line. The bear case? Revenue growth of 31.85% and gross margins of 48% are strong, but the market wants to see that flow to EBIT consistently — Q1 beat by 14% on that front, so maybe the tide turns. For now, neutral feels about right: good business, decent entry, but not compelling relative to other names in the space.
Roth/MKM throws in with a Buy and $75 PT on Ouster. That's 77% upside from $42.33. The firm sees Ouster as more than just a lidar vendor — it's a unified sensing + perception platform for physical AI (mobility, industrial, robotics, smart infra). The key thesis: firm pricing, revenue growth from AI autonomy adoption, and a path to cash flow breakeven by end of 2027.
"Ouster is positioned to outgrow the broader sensor market with advanced lidar and stereoscopic camera offerings that enable an AI-compute and software-based perception platform."
Recent dealflow backs the narrative — ARGUS (counter-drone), Gecko Robotics (inspection), and the FUJIFILM collab (color + 3D depth). Rosenblatt also upped PT to $53 last week. Stock's already up 259% in the past year, but still unprofitable ($185M rev, 57% y/y growth). Risk? Cash burn and execution at scale. Roth thinks the r/r works if physical AI adoption accelerates.
HC Wainwright fires the starting gun on DPRO today — Buy, $14 target, 80% upside from the current $7.79. That’s the first legitimate institutional piece of coverage on this name, and it matters. Thesis: Draganfly isn't just a drone parts shop — they’re a full-stack, field-proven operator with 20+ years of pedigree, now pulling real revenue ($285M mkt cap, 25% rev growth) and stacking contracts (DEVCOM counter-UAS, Blitz payloads, Skip Dynamix acquisition). The $14 target sits at the high end of an $8.97–$14.09 analyst range — but that’s a thin range because coverage is sparse. This initiation should widen it.
"H.C. Wainwright initiated coverage of Draganfly Inc. (NASDAQ:DPRO) with a Buy rating and a price target of $14.00... Draganfly has over two decades of drone innovation experience and offers full-stack end-to-end drone solutions that are integrated, compliant, and field-proven in Ukraine."
The Ukraine vector is the real narrative hook. Real combat-tested hardware, not a pitch deck. Needham already has a Buy / $12 out there. So you’ve got two buys in the book now — that’s momentum. Risk: still a sub-$300M mcap name, cash burn likely, and the counter-UAS contract with DEVCOM is early stage. But for a PM looking for small-cap drone exposure with actual revenue and a catalyst path, DPRO is the new kid worth a glance.
The beat was real but the composition was poison for the tape. Braze printed $211M in revenue (beat by 2.83%), 30% YoY growth, and raised top-line guidance to 22% YoY – but all the good news came from Professional Services, not Subscription. Subscription was in-line. Operating margin hit guidance but didn't get raised. In this tape, that's a recipe for selling. Cantor is leaning in, calling the noise a buying opportunity for the next 12 months.
"short-term noise as a buying opportunity for longer-term investors."
The broader analyst reaction is actually less dramatic than the stock's -28% YTD would suggest. DA Davidson, Stifel, Citizens, and Mizuho all kept Buy/Outperform ratings, with PTs ranging $30–$38 (versus $22.97 today). Stifel cited AI demand growth and improving net retention. Mizuho trimmed to $32 citing valuation but admits business performance is strong. Fourteen analysts revised earnings down, yet the street still carries a Strong Buy consensus. The tension is real: demand is there, margins are not expanding fast enough, and the tape wants proof of both simultaneously. Short-term r/r feels messy, but 12-month payoff skews hard to the upside if the core subscription engine reaccelerates.
RBC staying at $20 target on the Walmart Connect expanded partnership. Stock at $14.09 so that's a ~42% implied upside — but the real question is the ramp, not the headline. RBC sees it as incremental and positive for sentiment, but they're not rushing to change numbers yet.
Walmart is extending first-party audiences to Magnite's SSP, letting buyers reach those audiences across VIZIO CTV inventory. Closed-loop measurement tied to actual sales. That's the connective tissue that matters — commerce media meets TV, and Magnite is the plumbing.
"The firm assumes the partnership will take time to ramp but views it as an incremental opportunity and positive for sentiment around the company’s differentiation."
What's not in the article but worth flagging: MGNI also beat Q1 EPS ($0.13 vs $0.11 est) and revenue ($164.4M vs $159.2M) — yet stock slipped aftermarket. Classic "good print, wrong setup" for ad-tech. Walmart deal is a narrative catalyst but won't move the P&L next quarter. This is a positioning trade, not a fundamentals one. If you're long, you're betting the ramp starts showing in 2H comps. If you're short, you're betting CTV commoditization eats margin. Right now the market is saying "show me."
Uber is getting clobbered — down near its 52-week low at $70.92 — but Citizens is doubling down. Reiterates Market Outperform / $100 PT, betting the AV story is about to inflect. Waymo’s transition to the Ojai (6th-gen platform) was supply-constrained; now that the vehicle arrives with punch-outs and drive-by-wire pre-installed, production can ramp. Waymo reiterated “tens of thousands” annual guidance. For Uber, that means more AV miles on its network — and the non-Waymo AV partners (multiple expected H2 2026) add another leg.
“Autonomous vehicles fundamentally expand the ride share market” — Citizens. That’s the core bullish thesis: AVs don’t cannibalize Uber, they grow the TAM. The stock’s 40% below PT suggests the market isn’t buying it yet.
S&P upgraded Uber to BBB+ on $8B free cash flow and sub-1x debt/EBITDA — balance sheet is clean. Delivery Hero talks reportedly went nowhere (€10-11.5B offers rebuffed), but the appetite for M&A is real. DA Davidson and BTIG also reiterated Buys at $107/$100. The setup is contrarian: 19 analyst EPS revisions up, stock at 52-week low. Rate of change in AV deployment is the catalyst — if Ojai ramps H2 as planned, the narrative shifts.
PTs across the Street now clustering $205-215 (Truist to $215 from $180, Needham to $208, Stifel to $205) — all Buy-rated. The thesis is straightforward: TTMI is monetizing AI complexity through vertical integration, using FCF to fund M&A that drives differentiation and margin expansion. Stock's already ripped 536% in a year ($188.68, near 52w high $200.68) — so the debate is whether the multiple (Truist applying 38x on '27 EPS of $5.65) has room to run from here.
Analyst day messaging came in "less than expected" — but Truist explicitly calls the modest disappointment a buying opportunity, not a red flag. Revenue trajectory is the anchor: guiding to $4B by YE 2026 (+38% YoY). The bear case is that the stock already reflects a lot of that good news (InvestingPro flags overvalued). The bull case says the AI-driven PCB cycle is still early, and the M&A pipeline (Syracuse, Penang expansions) adds compounding optionality.
"The company is capitalizing on its AI opportunity and using cash flow to increase differentiation and expand its integrated electronics exposure, likely through mergers and acquisitions." — Truist on the strategic pivot
Cantor goes to $99 from $77, stays Overweight. The call is pure capacity math — they think the market is ignoring ~670MW of gross capacity coming online in 2027 plus 2028 additions. GPU pricing keeps trending up, which flows straight into the ARR target. Risk/reward still works at $64.
"The market is not accounting for approximately 670 megawatts of gross capacity IREN is bringing online in 2027."
Multiple expansion too: 7x 2028 EV/EBITDA vs prior 6.5x. The Dell deal ($1.6B for air-cooled Blackwell) and the $3B convertible (1% coupon, 32.5% premium) give them the balance sheet to build. BTIG also reiterated Buy at $80 after the FQ3 print. Bogeys range $41-$126 — wide divergence, but the crowd is still catching up to the build-out pace.
Jefferies was right to get more aggressive — and they're not alone in seeing the pivot. Raised PT to $56 from $44 (still Buy), and the numbers tell the story. FPS is a pure electrification play with a custom niche moat, and the order book is screaming.
THE HEADLINE: orders +308% vs a coverage-wide +100%. That's 3x the peer group. Backlog is extending in duration — not just a one-quarter pop. Jefferies now modeling FY28 sales/EBITDA 15-16% higher, and they see margin expansion as real optionality. FCF turns positive next year, and inorganic catalysts (bolt-on M&A) are flagged as imminent.
"Forgent has high leverage to the electrification theme through its custom niche business. Data center orders across coverage rose more than 100%, while FPS saw orders increase 308%."
The offset: the secondary offering — 42.3M shares priced at $47, with mixed primary/secondary components. That's why the stock dropped 8.5% after-hours despite the strong print. Neos Partners is trimming, and the company itself is raising equity. PMs need to decide if that's a tunnel-vision sell signal or a necessary funding step for the growth capex that backs the order book. I lean latter, but the after-hours move says the Street needs to digest the dilution.
Stock up 64% YTD, trading at $52.62 — fresh 52-week high territory. The r/r on a PT raise to $56 vs $52.62 is tight, but the rate of change on orders is accelerating, not decelerating. That's the kind of signal you pay up for in this tape.
Jefferies cuts PT to $9.80 (from $11.70), keeps Buy. Stock at $7.79 — near the 52-week low, implying 26% upside. The call is about ad spending divergence, not a broken model. Internet apps and auto verticals are firm; smartphones are soft. World Cup ad dollars are tricky this cycle — time zone mismatch with China is muting the typical boost.
Q1 delivered a revenue beat ($421.3M vs $418.42M consensus) but EPS of $0.34 missed the $0.35 whisper. That’s a nothing-burger miss on a stock trading at 5x P/E with a 7.3% dividend yield. The narrative is less about fundamental deterioration and more about ad mix shifts — and Jefferies thinks the company is smartly focusing on ROI, which should stabilize.
Not sure we can read too much into the World Cup time zone thing. It’s real, but it’s a one-off. The real signal is that WB’s core business (social + newsfeed) continues to print cash despite the macro. At these levels, the downside is protected by the balance sheet and buyback optionality. PMs should watch for a catalyst in H2 when smartphone ad comps ease.
TSM — BULLISH / HIGH. TSMC ADR +2% PRE-MARKET after Jensen met the CEO and core supply chain team. The message: demand is so strong it requires top-level resource coordination. CoWoS remains the binding constraint for advanced packaging. A14 node cuts power 30% vs N2, extending process lead and pricing power. The June shareholder meeting is the next catalyst — expect clarity on capacity expansion.
AMD — MIXED / MEDIUM. ROCm 7.2.4 fixes a memory copy latency regression in CPO mode on MI300X — a genuine inference improvement, not a feature drop. But a single 4x MI300X pod hitting rental market suggests some capacity may be loosening outside hyperscaler locked pools. Low confidence, but worth watching. Dell confirmed x86 bias for enterprise/air-cooled B200/B300, which is AMD's strongest segment — but NVDA is winning there too.
INTC — NEUTRAL / MEDIUM. MoU with 3DGS in India for glass core substrate packaging. First substantive semiconductor investment in India. Production not expected until 2027. Near-zero near-term earnings impact. The structural differentiator — zero Taiwan dependence in Xeon supply chain — is real but unmonetized. Stock dropped $5 in 10 minutes on index rebalancing (positioning, not fundamental). Turnaround remains a long path.
AVGO — BULLISH / HIGH. New all-time high at $446.77 ahead of earnings next week. The market is pricing in another strong quarter on AI infrastructure demand. Custom ASIC designs (Google TPU, potentially others) and networking silicon are the drivers. ByteDance's HBM-free chip is a double-edged sword — opens custom ASIC TAM for AVGO but also risks displacing NVDA GPUs in inference.
ARM — BULLISH / HIGH. 52-week high at $356. Dell confirmed ARM bias for liquid-cooled hyperscale deployments (GB200/GB300/Vera). Jensen confirmed NVDA Windows PC with ARM CPU. Multi-year shift to ARM in AI datacenter is accelerating. Key debate: can royalty rates and market share keep growing without RISC-V competition? For now, the trajectory is clear.
FDS — BULLISH / HIGH. Integrated MCP with Claude, automating 30+ hours of analyst work into 3 hours. Near-zero incremental COGS using proprietary data. The arbitrage is enormous — Claude costs ~$240/year vs $1,500-2,500 for a human analyst. This is the clearest example yet of SaaS incumbents becoming AI infrastructure rather than being disrupted. Margin expansion path is real.
LITE — BULLISH / MEDIUM. Key player in optical communications supply chain entering a shortage phase similar to HBM a year ago. Demand for 800G/1.6T optics is outpacing upstream AWG chip and WDM component capacity. The optical chain is becoming a bottleneck. CPO vs pluggable still undecided — but Lumentum benefits from the pricing and allocation environment either way.
COHR — BULLISH / MEDIUM. Same optical shortage thesis as LITE. Coherent is positioned to benefit from AI-driven optical capacity shortage and CPO transition. Also plays in power electronics and industrial lasers. The key debate is whether CPO disrupts existing pluggable margins faster than Coherent can transition.
GLW — BULLISH / HIGH. Corning expanding fiber production in tandem with Nvidia, but demand growth is outstripping capacity. Higher-density cabling and longer reaches in AI clusters drive demand. Fiber is becoming a bottleneck — GLW has pricing power in a constrained environment.
ASML — BULLISH / HIGH. CEO sees sporadic bottlenecks throughout chip supply chain for the foreseeable future. ASML is the gatekeeper for leading-edge EUV lithography. AI investment cycle driving foundries to order more tools. Key debate: can AI-driven capex sustain order levels beyond 2027? For now, ASML is a pure-play on semiconductor capex expansion.
VRT — BULLISH / HIGH. Power constraint is becoming the dominant bottleneck for AI deployment. ERCOT interconnection gap is the first public signal. Vertiv's thermal and power management solutions are essential as rack densities increase toward 300kW+. Dell confirmed "more cores, more DRAM, more NAND" per server — power demand per rack is accelerating.
OKLO — BULLISH / LOW. Partnering with Newcleo ($780M war chest) to debut a $2.4B SPAC. Nuclear fuel cycle positioning targets SMR market for AI data center power. SMRs are the only technology that can provide 100MW+ blocks without waiting 3-7 years for grid interconnection (assuming regulatory approval). Speculative but directionally correct.
NOW — BULLISH / MEDIUM. Up 14% as part of the software revenge trade. Reclaimed the 200-day moving average for the first time in months. Bellwether for enterprise AI adoption through workflow automation. Key debate: sustainable value rotation or short squeeze? The rotation from semis to software is showing in price action.
PLTR — BULLISH / LOW. Up 9% in the software revenge trade. Direct beneficiary of government and enterprise AI adoption via AIP platform. Key debate is valuation — trades at a premium multiple. AI revenue growth is accelerating, but the stock is highly volatile and moves on narrative shifts.
ORCL — BULLISH / MEDIUM. Up 7-8% in the software revenge trade. Cloud infrastructure (OCI) growing rapidly as a platform for AI workloads. Signed large AI deals with OpenAI and others. Long-term debate: can Oracle compete with AWS, Azure, and GCP? Near-term, the AI narrative is driving multiple expansion.
Hearing ByteDance is building a Groq LPU-style inference chip that avoids HBM entirely. Architecture uses InnoStar RRAM on TSMC mature nodes (outside US export controls). This is a structural read-through: (a) hyperscalers are aggressively custom-designing inference silicon to escape NVDA GPU pricing and HBM availability, (b) avoiding HBM sidesteps the current binding constraint and US export controls. If this works at scale, it pressures both NVDA (GPU demand) and the HBM suppliers (MU, SK Hynix, Samsung) by creating an alternative architecture. Early stage, but the direction is clear.
Word is ERCOT's interconnection queue is the first public signal of a systemic problem. Datacenter interconnect requests massively exceed what the grid operator will underwrite — 3-7 year queue for grid hookups. This means behind-the-meter solutions (nuclear, fuel cells, on-site generation) are the only path to deploy outside that timeline. Watching for any GW approval or denial in ERCOT/PJM/CAISO — those will be first-order reads on AI deployment timeline.
Channel checks suggest the optical supply chain shortage is real and accelerating. Corning and Nvidia expanding fiber production simultaneously, but demand growth is outpacing capacity. The bottleneck is upstream AWG chips and WDM components at mature nodes — not process technology barriers. This means the shortage is solvable faster than HBM, but price pressure will be acute in the near term. First CPO test equipment data points (Chroma/Chroma ATE's insertion orders for 6月试产) are the earliest verifiable signal.
Scuttlebutt on the Dell squeeze: the +31% move was short covering driving the open, not new fundamental information. Float is small (vintage equity structure limits supply elasticity). Real money is still deciding whether to add to positions. If the consolidation holds above $X, it becomes a buy-the-dip setup for PMs who missed the initial move.
Rumor: OKLO/Newcleo SPAC at $2.4B is targeting SMR deployment for AI datacenters. Nuclear regulatory approval is the gating factor. If the DOE or NRC signals faster licensing timelines, this becomes investable. Until then, it's a lottery ticket on a structural need — but the need is real, and the bet is on policy acceleration, not technology risk.
Heard Samsung workers getting $400K bonuses on AI profits. This is the labor market signaling that AI-driven semiconductor profitability is structurally different from cyclical upturns. If Samsung is willing to lock in labor at these levels, management believes the cycle is multi-year, not a spike. This is a contrarian signal against the "cycle top is coming" bears.
Word on the street: the software revenge trade has legs for now, but positioning is getting crowded. The rotation from semis to software is showing in price action (NOW, PLTR, ORCL all up 7-14%). But the macro catalyst is the same — AI enterprise adoption driving workflow automation demand. The risk is that software names don't have the direct AI revenue exposure that semis do, and if enterprise IT budgets slow, these names will get hit first.